Skip to main content

amikacin

Generic: AMIKACIN SULFATE·Brand: AMIKACIN SULFATE, AMIKACIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, AMIKIN, AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, ARIKAYCE KIT, Arikayce

amikacin: 1 clinical trial tracked.

amikacin evidence translation

What we can confirm

1 tracked trial

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about amikacin, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

Clinical Trials (1)

A Multi-centre, Randomised Trial Comparing a Novel Combination Treatment (Arm D - Intravenous Sulbactam-durlobactam in Combination With Intravenous Ceftriaxone, Oral Amoxicillin, Oral Azithromycin and Oral Clofazimine) Versus Standard of Care Treatments for the Intensive Phase of Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial

NCT07485010·Phase 2
Not yet recruiting

Primary endpoint: The primary outcome of the Intervention Program is microbiological clearance of Mycobacterium abscessus (MABS) with good tolerance of the interventions.

InterventionalRandomizedopen300 targetStarted 2027-04Completion 2031-07The University of Queensland